» Articles » PMID: 30659095

Structural Insights into the Tyrosine Phosphorylation-mediated Inhibition of SH3 Domain-ligand Interactions

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2019 Jan 20
PMID 30659095
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Src homology 3 (SH3) domains bind proline-rich linear motifs in eukaryotes. By mediating inter- and intramolecular interactions, they regulate the functions of many proteins involved in a wide variety of signal transduction pathways. Phosphorylation at different tyrosine residues in SH3 domains has been reported previously. In several cases, the functional consequences have also been investigated. However, a full understanding of the effects of tyrosine phosphorylation on the ligand interactions and cellular functions of SH3 domains requires detailed structural, atomic-resolution studies along with biochemical and biophysical analyses. Here, we present the first crystal structures of tyrosine-phosphorylated human SH3 domains derived from the Abelson-family kinases ABL1 and ABL2 at 1.6 and 1.4 Å resolutions, respectively. The structures revealed that simultaneous phosphorylation of Tyr and Tyr in ABL1 or the homologous residues Tyr and Tyr in ABL2 induces only minor structural perturbations. Instead, the phosphate groups sterically blocked the ligand-binding grooves, thereby strongly inhibiting the interaction with proline-rich peptide ligands. Although some crystal contact surfaces involving phosphotyrosines suggested the possibility of tyrosine phosphorylation-induced dimerization, we excluded this possibility by using small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and NMR relaxation analyses. Extensive analysis of relevant databases and literature revealed not only that the residues phosphorylated in our model systems are well-conserved in other human SH3 domains, but that the corresponding tyrosines are known phosphorylation sites in many cases. We conclude that tyrosine phosphorylation might be a mechanism involved in the regulation of the human SH3 interactome.

Citing Articles

Post-translational modifications in the Protein Data Bank.

Schofield L, Dialpuri J, Murshudov G, Agirre J Acta Crystallogr D Struct Biol. 2024; 80(Pt 9):647-660.

PMID: 39207896 PMC: 11394121. DOI: 10.1107/S2059798324007794.


TMEA, a Polyphenol in , Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling.

Li H, Jiang X, Shen X, Sun Y, Jiang N, Zeng J Front Cell Dev Biol. 2021; 9:708331.

PMID: 34485295 PMC: 8416095. DOI: 10.3389/fcell.2021.708331.


Characterization of the Intramolecular Interactions and Regulatory Mechanisms of the Scaffold Protein Tks4.

Mero B, Koprivanacz K, Cserkaszky A, Radnai L, Vas V, Kudlik G Int J Mol Sci. 2021; 22(15).

PMID: 34360869 PMC: 8348221. DOI: 10.3390/ijms22158103.


Novel Roles of SH2 and SH3 Domains in Lipid Binding.

Sipeki S, Koprivanacz K, Takacs T, Kurilla A, Laszlo L, Vas V Cells. 2021; 10(5).

PMID: 34068055 PMC: 8152464. DOI: 10.3390/cells10051191.


Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.

Hallumi E, Shalah R, Lo W, Corso J, Oz I, Beach D J Immunol. 2021; 206(10):2322-2337.

PMID: 33931484 PMC: 8113088. DOI: 10.4049/jimmunol.2001053.


References
1.
Gmeiner W, Horita D . Implications of SH3 domain structure and dynamics for protein regulation and drug design. Cell Biochem Biophys. 2002; 35(2):127-40. DOI: 10.1385/CBB:35:2:127. View

2.
Fan P, Cong F, Goff S . Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1. Cancer Res. 2003; 63(4):873-7. View

3.
Micsonai A, Wien F, Kernya L, Lee Y, Goto Y, Refregiers M . Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc Natl Acad Sci U S A. 2015; 112(24):E3095-103. PMC: 4475991. DOI: 10.1073/pnas.1500851112. View

4.
Tatarova Z, Brabek J, Rosel D, Novotny M . SH3 domain tyrosine phosphorylation--sites, role and evolution. PLoS One. 2012; 7(5):e36310. PMC: 3352900. DOI: 10.1371/journal.pone.0036310. View

5.
Chen S, OReilly L, Smithgall T, Engen J . Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core. J Mol Biol. 2008; 383(2):414-23. PMC: 2596866. DOI: 10.1016/j.jmb.2008.08.040. View